US FDA approves Neurocrine Biosciences’ Crenessity to treat children and adults with classic congenital adrenal hyperplasia: San Diego Monday, December 16, 2024, 16:00 Hrs [IST] ...

The US Food and Drug Administration has approved Crinecerfont for treatment of classic congenital adrenal hyperplasia, ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

which can occur if patients with underlying adrenal insufficiency who do not also receive adequate doses of glucocorticoid replacement therapy in situations associated with increased cortisol need ...

Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...

Adrenogenital Syndrome Treatment Market. The global adrenogenital syndrome treatment market is poised for substantial growth, ...

The concept of a tapering schedule for chronic corticosteroid therapy evolved to prevent adrenal insufficiency syndrome and recurrence or exacerbation of signs and symptom. Patients are more ...

Mama June's daughter, Anna Cardwell, died on December 9, 2023, after being diagnosed with stage four adrenal carcinoma last ...

A 36-year-old man with a 6-month history of asthenia, impotence, loss of libido, polyuria, and polydipsia attended our department; he also reported needing to wake up twice at night to urinate and ...

Oppenheimer analyst Leland Gershell has maintained their neutral stance on SPRB stock, giving a Hold rating yesterday.Pick the best stocks and ...

Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both immunology and endocrinology, is collaborating with ...